ПБиМ 2023 №1 (142)
Subject of the article
CONTRAST-INDUCED NEPHROPATHY IN POST COVID-19 PATIENTS (223-229)
Authors
Abdashimov Z.B., Khodzhibekova Yu.M., Yunusova L.R.
Institution
Samarkand State Medical University, Tashkent State Dental Institute
Abstract
Over the past 30 years, the use of radiopaque agents (RCS) has significantly increased during urography, angiography, computed tomography and surgical procedures. About 60 million doses of RCS are used annually in the world, but despite the use of newer and less nephrotoxic drugs, the risk of contrastinduced nephropathy (CIN) remains significant, especially among patients with previous renal impairment. Contrast-induced nephropathy is a serious cause of acute kidney injury and is an urgent problem in clinical practice. To date, there are contradictions in the understanding of many aspects of KIN.However, the current situation with the use of contrast agents in patients with COVID-19 and causing KIN has become an urgent issue for clinicians and radiologists.
Key words
contrast-induced nephropathy, radiopaque agents, COVID-19.
Literature
1. Г.О. Исаев, О.Ю. Миронова, В.В. Фомин. Оценка влияния различных факторов на риск раз-вития новой коронавирусной инфекции у пациен-тов, перенесших контрастиндуцированное острое повреждение почек. Терапевтический архив. 2021; 93 (6): 667–671. 2. Юнусова Л.Р., Икрамов Г.О., Халманов Б.А., Сувонов К.Ж. МСКТ диагностика остеомиелита верхней челюсти, у пациентов перенесших COVID-19./Л.Р. Юнусова // Вестник современной клинической медицины. 2022; Т. 15, вып. 5. - С. 81-85. DOI:10.20969/VSKM.2022.15(5).81-85. 3. Fattaeva D. R., Rizaev J. A., Rakhimova D. A. Efficiency of Different Modes of Therapy for Higher Sinus after COVID-19 in Chronic Obstructive Pul-monary Disease //Annals of the Romanian Society for Cell Biology. – 2021. – С. 6378–6383-6378–6383. 4. Rizaev J. A., Rizaev E. A., Akhmadaliev N. N. Current view of the problem: A new approach to COVID-19 treatment //Indian Journal of Forensic Medicine & Toxicology. – 2020. – Т. 14. – №. 4. – С. 7341-7347. 5. Rizaev J. A., Khaidarov N. K., Abdullaev S. Y. Current approach to the diagnosis and treatment of glossalgia (literature review) //World Bulletin of Pub-lic Health. – 2021. – Т. 4. – С. 96-98. 6. Rizaev J. A., Sh A. M. Covid-19 views on immu-nological aspects of the oral mucosa //European re-search: innovation in science, education and technol-ogy. – 2022. – С. 111-113. 7. Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(6):1530-9. DOI:10.1016/j.kint.2020.07.030 8. Pranata R, Supriyadi R, Huang I, et al. The asso-ciation between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis. Clin Med Insights Circ Respir Pulm Med. 2020;14:1179548420959165. DOI:10.1177/1179548420959165 9. Tadic M, Cuspidi C, Grassi G, Mancia GM. COVID‐19 and arterial hypertension: Hypothesis or evidence? J Clin Hypertens.2020;22(7):1120-6. DOI:10.1111/jch.13925 10. Zuin M, Rigatelli G, Zuliani G, et al. Arterial hy-pertension and risk of death in patients with COVID-19 infection: systematic review and metaanalysis. J Infect. 2020;81(1):e84-6. DOI:10.1016/j.jinf.2020.03.059 11. Roncon L, Zuin M, Zuliani G, Rigatelli G. Pa-tients with arterial hypertension and COVID-19 are at higher risk of ICU admission. BrJ Anaesth.2020; 125 (2):Р.254-5. DOI:10.1016/j.bja.2020.04.056 12. Harjai KJ, Raizada A, Shenoy C, et al. A compar-ison of contemporary definitions of contrast nephrop-athy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol. 2008;101(6):812-9.DOI:10.1016/j.amjcard.2007.10.051 13. Mitchell AM, Jones AE, Tumlin JA, Kline JA. Incidence of contrastinduced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol. 2010;5(1):4-9.DOI:10.2215/CJN.05200709